136 related articles for article (PubMed ID: 6581152)
1. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
Hoshino T; Sekine Y; Fujiwara A
J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
[TBL] [Abstract][Full Text] [Related]
3. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
[TBL] [Abstract][Full Text] [Related]
4. Microbial conversion of anthracycline antibiotics. IV. Study on the glycosidation of epsilon-pyrromycinone by Streptomyces galilaeus OBB-111-848.
Hoshino T; Fujiwara A
J Antibiot (Tokyo); 1984 Nov; 37(11):1473-4. PubMed ID: 6511669
[No Abstract] [Full Text] [Related]
5. Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutants.
Ylihonko K; Hakala J; Niemi J; Lundell J; Mäntsälä P
Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1359-65. PubMed ID: 8081501
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
[TBL] [Abstract][Full Text] [Related]
7. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
[TBL] [Abstract][Full Text] [Related]
8. Microbial conversion of anthracycline antibiotics. II. Characterization of the microbial conversion products of auramycinone by Streptomyces coeruleorubidus ATCC 31276.
Hoshino T; Fujiwara A
J Antibiot (Tokyo); 1983 Nov; 36(11):1463-7. PubMed ID: 6654755
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius.
Schumann G; Stengel C; Eckardt K; Ihn W
J Basic Microbiol; 1986; 26(4):249-55. PubMed ID: 3464736
[TBL] [Abstract][Full Text] [Related]
10. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
[TBL] [Abstract][Full Text] [Related]
11. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products.
Wang Y; Niemi J; Mäntsälä P
FEMS Microbiol Lett; 2002 Feb; 208(1):117-22. PubMed ID: 11934504
[TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatographic determination of aclacinomycin A and its related compounds. I. Normal phase HPLC for monitoring fermentation and purification processes.
Ogasawara T; Goto S; Mori S; Oki T
J Antibiot (Tokyo); 1981 Jan; 34(1):47-51. PubMed ID: 6941957
[TBL] [Abstract][Full Text] [Related]
13. Aklanonic acid-producing mutants of Streptomyces galilaeus and Streptomyces peucetius var. caesius.
Schlegel B; Stengel C; Schumann G; Prauser H; Eckardt K
J Basic Microbiol; 1987; 27(2):107-11. PubMed ID: 3477632
[TBL] [Abstract][Full Text] [Related]
14. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
Kim HS; Hong YS; Kim YH; Yoo OJ; Lee JJ
J Antibiot (Tokyo); 1996 Apr; 49(4):355-60. PubMed ID: 8641998
[TBL] [Abstract][Full Text] [Related]
15. New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1.
Tobe H; Yoshimoto A; Ishikura T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Dec; 35(12):1641-5. PubMed ID: 6962794
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of aklavinone and aclacinomycins.
Kitamura I; Tobe H; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Nov; 34(11):1498-500. PubMed ID: 7319911
[No Abstract] [Full Text] [Related]
17. New anthracycline antibiotics.
Oki T
Jpn J Antibiot; 1977 Dec; 30 Suppl():70-84. PubMed ID: 612711
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline antibiotic 2-hydroxyaclacinomycins. I. 2-Hydroxyaclacinomycin-producing recombinant obtained from aclacinomycin-blocked mutants of Streptomyces galilaeus by a technique of protoplast fusion.
Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
Jpn J Antibiot; 1991 Mar; 44(3):269-76. PubMed ID: 1880909
[TBL] [Abstract][Full Text] [Related]
19. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
Hwang CK; Kim HS; Hong YS; Kim YH; Hong SK; Kim SJ; Lee JJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1616-20. PubMed ID: 7492117
[TBL] [Abstract][Full Text] [Related]
20. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
Kim HS; Kim YH; Yoo OJ; Lee JJ
Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
